https://healthnewsdominicanrepublic.com/article/911051172-oculis-announces-agreement-with-fda-on-a-special-protocol-assessment-spa-for-optic-neuritis-registrational-trial
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis...
https://ggba.swiss/en/vaud-based-ophthalmic-treatments-specialist-oculis-raises-57-million/
Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million - Greater Geneva Bern area
Jul 4, 2023 - A biopharmaceutical company focused on developing innovative ophthalmic treatments, Oculis has announced the closing of an oversubscribed $ 57 million Series C...
https://www.edgen.tech/stock/OCS
Oculis Holding AG (OCS) Stock Price, Chart, News and AI analysis | Edgen
The live Oculis Holding AG price today is 30.29, with price change +0.23%. We update OCS price, chart, AI signals, news and report real-time
stock price chartholding ag
https://www.oculis-amari.de/galerien/familiengl%C3%BCck/babybauch/
Oculis Amari - Fotografie von Anja Schwartz Langelsheim bei Goslar - Babybauch
Willkommen bei Oculis Amari - alles rund um die Fotografin Anja Schwartz in Langelsheim bei Goslar im Harz. Businessfotografie, Portraitfotografie,...
oculisamarifotografievonanja
https://knova.um.edu.my/research_publications_2021_2025/5299/
"Targeting sine oculis homeoprotein 1 (SIX1): A review of oncogenic rol" by Zhiwei Bian, Menny M....
Sine oculis homeoprotein 1 (SIX1), a prominent representative of the homeodomain transcription factors within the SIX family, has attracted significant...
https://oculis.com/publications/topical-dexamethasone-cyclodextrin-microparticle-eye-drops-for-diabetic-macular-edema/
Topical Dexamethasone-Cyclodextrin Microparticle Eye Drops For Diabetic Macular Edema - Oculis
diabetic macular edemaeye dropstopicaldexamethasonecyclodextrin
https://scitechtodaybhutan.com/article/911051172-oculis-announces-agreement-with-fda-on-a-special-protocol-assessment-spa-for-optic-neuritis-registrational-trial
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis...
https://africamarketingindustrynews.com/article/864498272-oculis-to-participate-in-upcoming-november-investor-conferences
Oculis to Participate in Upcoming November Investor Conferences | Africa Marketing Industry News
to participate
https://oculis.com/oculis-to-participate-at-upcoming-investor-conferences/
Oculis to Participate at Upcoming Investor Conferences - Oculis
to participateoculisupcominginvestorconferences
https://pawpures.com/
Oculis
oculis
https://www.georgianbusinesstimes.com/article/911051172-oculis-announces-agreement-with-fda-on-a-special-protocol-assessment-spa-for-optic-neuritis-registrational-trial
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis...
https://www.biospace.com/oculis-announces-completion-of-enrollment-in-phase-2-randomized-controlled-acuity-trial-with-ocs-05-for-acute-optic-neuritis
Oculis Announces Completion of Enrollment in Phase 2 Randomized Controlled ACUITY Trial with OCS-05...
May 9, 2024 - Oculis Holding AG announced the completion of enrollment in its multi-center, randomized, double-blind, placebo-controlled Phase 2 ACUITY trial evaluating the...
https://www.lumiconnect.com/fr/events/oculisagm2026
2026 Annual General Meeting of Oculis Holding AG | Register to submit voting instructions
annual general meeting
https://www.home.saxo/da-dk/markets/stocks/ocs-xnas
Oculis Holding AG aktie | Saxo
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care.
holding agoculisaktiesaxo
https://www.ophthalmologymanagement.com/issues/2025/may/industry-insider/
Oculis CEO Riad Sherif, MD | Ophthalmology Management
Oct 29, 2025 - Riad Sherif, MD, discusses positive data from Oculis' phase 2 ACUITY trial of OCS-05 in acute optic neuritis, the significance this neuroprotective treatment...
oculisceoriadsherifmd
https://eqtgroup.com/about/current-portfolio/oculis-holding-ag
Oculis | EQT Portfolio
Oculis is a biopharmaceutical company active in the field of eyecare.
oculiseqtportfolio
https://techreportervirginislands.com/article/836103729-oculis-upsized-loan-facility-to-access-up-to-chf-100-million
Oculis Upsized Loan Facility to Access up to CHF 100 million | Tech Reporter Virgin Islands
https://oculis.com/oculis-publishes-notifications-of-transactions-by-persons-discharging-managerial-responsibilities-3-2/
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities -...
oculispublishesnotificationstransactionspersons
https://easttimortechnologypress.com/article/836103729-oculis-upsized-loan-facility-to-access-up-to-chf-100-million
Oculis Upsized Loan Facility to Access up to CHF 100 million | East Timor Technology Press